227 related articles for article (PubMed ID: 20016020)
21. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
22. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
[TBL] [Abstract][Full Text] [Related]
23. Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.
Arendrup MC; Pfaller MA;
Antimicrob Agents Chemother; 2012 Jul; 56(7):3965-8. PubMed ID: 22564836
[TBL] [Abstract][Full Text] [Related]
24. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Garcia-Effron G; Kontoyiannis DP; Lewis RE; Perlin DS
Antimicrob Agents Chemother; 2008 Nov; 52(11):4181-3. PubMed ID: 18794386
[TBL] [Abstract][Full Text] [Related]
25. Silver and gold nanostructures: antifungal property of different shapes of these nanostructures on Candida species.
Jebali A; Hajjar FH; Pourdanesh F; Hekmatimoghaddam S; Kazemi B; Masoudi A; Daliri K; Sedighi N
Med Mycol; 2014 Jan; 52(1):65-72. PubMed ID: 23968285
[TBL] [Abstract][Full Text] [Related]
26. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
[TBL] [Abstract][Full Text] [Related]
27. Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
Pai MP; Samples ML; Mercier RC; Spilde MN
Antimicrob Agents Chemother; 2008 Jul; 52(7):2367-76. PubMed ID: 18426896
[TBL] [Abstract][Full Text] [Related]
28. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
29. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Thompson GR; Wiederhold NP; Vallor AC; Villareal NC; Lewis JS; Patterson TF
Antimicrob Agents Chemother; 2008 Oct; 52(10):3783-5. PubMed ID: 18676885
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
Brzankalski GE; Najvar LK; Wiederhold NP; Bocanegra R; Fothergill AW; Rinaldi MG; Pattterson TF; Graybill JR
J Antimicrob Chemother; 2008 Nov; 62(5):1094-100. PubMed ID: 18658194
[TBL] [Abstract][Full Text] [Related]
31. New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study.
Rodríguez-Leguizamón G; Fiori A; Lagrou K; Gaona MA; Ibáñez M; Patarroyo MA; Van Dijck P; Gómez-López A
BMC Infect Dis; 2015 Feb; 15():108. PubMed ID: 25888031
[TBL] [Abstract][Full Text] [Related]
32. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
[TBL] [Abstract][Full Text] [Related]
33. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
[TBL] [Abstract][Full Text] [Related]
34. Dose escalation studies with caspofungin against Candida glabrata.
Domán M; Kovács R; Perlin DS; Kardos G; Gesztelyi R; Juhász B; Bozó A; Majoros L
J Med Microbiol; 2015 Sep; 64(9):998-1007. PubMed ID: 26296340
[TBL] [Abstract][Full Text] [Related]
35. Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance.
Ghannoum MA; Herbert J; Isham N
Mycoses; 2011 Jul; 54(4):e175-7. PubMed ID: 20236241
[TBL] [Abstract][Full Text] [Related]
36. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
[TBL] [Abstract][Full Text] [Related]
37. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
[TBL] [Abstract][Full Text] [Related]
38. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
[TBL] [Abstract][Full Text] [Related]
39. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
40. Caspofungin for invasive candidiasis at a tertiary care medical center.
Zaas AK; Dodds Ashley ES; Alexander BD; Johnson MD; Perfect JR
Am J Med; 2006 Nov; 119(11):993.e1-6. PubMed ID: 17071169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
